INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 137 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $458,392 | -17.3% | 8,800 | +0.6% | 0.03% | -16.7% |
| Q2 2023 | $554,113 | +18.2% | 8,751 | +1.1% | 0.04% | +28.6% |
| Q1 2023 | $468,722 | +2.6% | 8,656 | +0.3% | 0.03% | +16.7% |
| Q4 2022 | $456,700 | +6.5% | 8,630 | -6.4% | 0.02% | +60.0% |
| Q3 2022 | $429,000 | -32.4% | 9,217 | -17.1% | 0.02% | -16.7% |
| Q2 2022 | $635,000 | +3.8% | 11,124 | +11.2% | 0.02% | 0.0% |
| Q1 2022 | $612,000 | +14.6% | 10,007 | -1.9% | 0.02% | +28.6% |
| Q4 2021 | $534,000 | +2.3% | 10,198 | -27.2% | 0.01% | +7.7% |
| Q3 2021 | $522,000 | +16.3% | 14,000 | +27.3% | 0.01% | 0.0% |
| Q2 2021 | $449,000 | +14866.7% | 11,000 | +10900.0% | 0.01% | – |
| Q3 2020 | $3,000 | -97.6% | 100 | -97.9% | 0.00% | -100.0% |
| Q2 2020 | $123,000 | +12200.0% | 4,800 | +4700.0% | 0.01% | – |
| Q3 2019 | $1,000 | -66.7% | 100 | -50.0% | 0.00% | – |
| Q2 2019 | $3,000 | -95.4% | 200 | -96.2% | 0.00% | -100.0% |
| Q1 2019 | $65,000 | +1200.0% | 5,318 | +1139.6% | 0.00% | – |
| Q4 2018 | $5,000 | -98.8% | 429 | -97.8% | 0.00% | -100.0% |
| Q3 2018 | $418,000 | +24.0% | 19,280 | +0.9% | 0.02% | +14.3% |
| Q2 2018 | $337,000 | -14.0% | 19,099 | +2.4% | 0.02% | -25.0% |
| Q1 2018 | $392,000 | +2205.9% | 18,645 | +1486.8% | 0.03% | +2700.0% |
| Q4 2017 | $17,000 | -39.3% | 1,175 | -33.3% | 0.00% | -66.7% |
| Q3 2017 | $28,000 | -52.5% | 1,762 | -62.6% | 0.00% | -50.0% |
| Q2 2017 | $59,000 | -60.7% | 4,715 | -48.8% | 0.01% | -57.1% |
| Q1 2017 | $150,000 | -65.0% | 9,200 | -67.3% | 0.01% | -68.9% |
| Q3 2016 | $429,000 | +68.2% | 28,136 | +328.3% | 0.04% | +25.0% |
| Q2 2016 | $255,000 | +20.3% | 6,569 | -14.0% | 0.04% | +20.0% |
| Q1 2016 | $212,000 | – | 7,639 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |